Merck & Co (MSD), Alexion, and AstraZeneca Rare Disease have reported positive topline outcomes from the Phase III KOMET ...

"Aethlon Medical enrols first patient in trial of Hemopurifier device for cancer " was originally created and published by ...

Citius Pharmaceuticals (CTXR) and Citius Oncology (CTOR) announced “promising” preliminary results from an ongoing ...

Axicabtagene ciloleucel, known by the brand name Yescarta, has been accepted for treating adults with two types of blood cancer.

developed it and brought it to market in a host of cancer indications under the brand name Keytruda. Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights ...

I'm not saying the stocks on this list can generate those kinds of returns. But they are trading at discounted valuations, and investing $5,000 into them can be a good move. Prudent investors will ...

South Korea’s Celltrion has started work on a biosimilar version of pembrolizumab, Merck & Co’s blockbuster immunotherapy Keytruda ... to be known under the brand name of Ontruzant and ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Pipeline and key clinical candidates for these companies: ...

Lakeside Holding Limited ("Lakeside" or the "Company") , a U.S.-based integrated cross-border supply chain solution provider with a strategic focus on the Asian market operating under the brand ...

Biotheus’ antibody drug targets PD-L1 and VEGF, a design that’s high on drugmakers’ radars after the success of Summit ...

“Deals of Desire” will run on TV, TikTok, YouTube and out-of-home and follows similar efforts from the retailer that bridge content and commerce.

After hours: 8 November at 18:48 GMT-5 ...